Board of Directors

Board of Directors

 

The Company has 8 directors, including 4 independent directors. The terms of office is 3 year. Board of directors are selected based on their professionalism and diverse background, the selected criteria includes business management, business operation, finance and accounting, industrial knowledge, crisis management and leadership skill.

Term of the 11th Board of Directors: June 6, 2023 to June 5, 2026

 

Title Name Gender Work experience and educational background
Chairman Sheng Pao-Shi Male

Bachelor of Economics, University of California, Berkeley

General Manager, Hoan Pharmaceuticals Ltd.

Director Shen Shang-Hung Male

Department of Electrical Engineering, National Taiwan University

MBA US Emory University

Manager, Electronic Engineering Department, US AT&T

Director Chen Kuan-Pai Male

MBA, University of Southern California (USC)

Chairman, Hundred River International Investment Corp.

Director Chen Shih-Min Male

Ph.D., School of Pharmacy, Taipei Medical University

Masters, Department of Chemistry, National Chung Hsing University

Business Development Manager, Hoan Pharmaceuticals Ltd.

Assistant R&D Project Manager, United Biomedical, Inc., Asia /Assistant Manager, R&D Planning Department, Technology Division

Section Head, Synpac-Kingdom Pharmaceutical Co., Ltd.

Researcher, Medical and Pharmaceutical Industry Technology and Development Center

Independent Director Lin Jui-Yi Male

MBA, George Washington University

President, Shung Ye Trading Co., Ltd.

Independent Director Lai Ming-Jung Male

EMBA, Advanced Finance Program, National Chengchi University

Executive Director, Advisory Department, EY Taiwan

Executive Director, Assurance Department, EY Taiwan

Independent Director Lee Yi-Chin Male

Master and Ph.D, Resource Planning, Civil Engineering Department, Stanford University

Senior Consultant, McKinsey & Co.

President, China Food Co., Ltd.

Independent Director Lin Hsin-I Female

Master of Law, Columbia University

Partner, Lex Pro Attorney-at-Law